Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency .
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSohag University
About this trial
Association between Benign Paroxysmal Positional Vertigo and Vitamin D deficiency
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Cases: Adults with a confirmed diagnosis of idiopathic BPPV based on positive Dix-Hallpike maneuver (nystagmus and vertigo lasting <1 minute).
Controls: Adults attending ENT clinic without history of vertigo or BPPV, confirmed by negative Dix-Hallpike test.
Disqualifiers
Known causes of secondary vertigo (e.g., Meniere's disease, vestibular neuritis, central vertigo).
Conditions affecting vitamin D metabolism (e.g., chronic kidney disease, malabsorption syndromes, hyperparathyroidism).
Use of medications interfering with vitamin D levels (e.g., anticonvulsants, glucocorticoids) in the past 3 months.
Pregnancy or lactation.
Trial population
Otolaryngology (ENT) Outpatient Clinic and Audiovestibular unit at Sohag University Hospital, Sohag, Egypt.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Vitamin D
Diagnostic testLevel of Vitamin D
Treatment groups
160 Participants
are divided into 2 treatment groupsGroup A: case1 intervention
Group B: control1 intervention
Trial outcomes
Primary outcomes
1
Level of Vitamin D in patients with Benign Paroxysmal Positional Vertigo
Time frame
From enrollment to 1 months after investigationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov